- acetylcysteine
- Trade Name: Acetadote
- Indication: For the use of Acetadote(registered TM) Injection, administered intravenously within 8 to 10 hours after ingestion of a potentially heptotoxic quantity of acetaminophen, to prevent or lessen hepatic injur
- Company: Cumberland Pharmaceuticals, Inc.
- acetylcysteine effervescent tablets for oral solution
- Trade Name: Cetylev
- Indication: Indicated to prevent or lessen hepatic injury after ingestion of a potentially hepatotoxic quantity of acetaminophen in patients with acute ingestion or from repeated supratherapeutic ingestion
- Company: Arbor Pharmaceuticals, Inc.
- adalimumab
- Trade Name: Humira
- Indication: Reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years to 4 years of age.
- Company: AbbVie Inc.
- adalimumab-1
- Trade Name: Humira
- Indication: Reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 4 years of age and older.
- Company: AbbVie Inc.
- adalimumab-2
- Trade Name: Humira
- Indication: Indicated for the treatment of non-infectious intermediate, posterior and panuveitis in adult patients
- Company: AbbVie, Inc.
- adalimumab-3
- Trade Name: Humira
- Indication: Treatment of moderate to severe hidradenitis suppurativa
- Company: AbbVie, Inc.
- adalimumab-4
- Trade Name: Humira
- Indication: Reducing signs and symptoms and inducing and maintaining clinical remission in patients 6 years of age and older with moderately to severely active Crohn's disease who have had an inadequate response to corticosteroids or immunomodulators such as azathioprine, 6-mercaptopurine, or methotrexate. (Orphan approval for patients from 6 through 16 years of age.)
- Company: AbbVie, Inc.
- afatinib
- Trade Name: Gilotrif(R)
- Indication: Treatment of patients with metastatic, squamous, non-small cell lung cancer progressing after platinum-based chemotherapy
- Company: Boehringer Ingelheim Pharmaceuticals, Inc.
- afatinib-1
- Trade Name: Gilotrif
- Indication: First-line treatment of patients with metastatic non-small cell lung cancer (NSCLS) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test.
- Company: Boehringer Ingelheim Pharmaceuticals, Inc.
- Albendazole
- Trade Name: Albenza
- Indication: Treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, Taenia solium.
- Company: Amedra Pharmaceuticals LLC
- Albendazole-1
- Trade Name: Albenza
- Indication: Treatment of cystic hydatid disease of the liver, lung, and peritoneum, caused by the larval form of the dog tapeworm, Echinococcus granulosus.
- Company: Amedra Pharmaceuticals LLC
- Aldesleukin
- Trade Name: Proleukin
- Indication: Treatment of adults (>18 years old) with metastatic renal cell carcinoma.
- Company: Chiron Corporation
- Aldesleukin-1
- Trade Name: Proleukin
- Indication: Treatment of adults with metastatic melanoma.
- Company: Chiron Corporation
- alectinib
- Trade Name: Alecensa
- Indication: Treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC), who have progressed on or are intolerant to crizotinib
- Company: Genentech, Inc.
- alemtuzumab
- Trade Name: Campath
- Indication: The treatment of patients with B-cell chronic lymphocytic leukemia who have been treated with alkylating agents and who have failed fludarabine therapy.
- Company: Genzyme Corporation
- Alglucerase injection
- Trade Name: Ceredase
- Indication: Long-term enzyme replacement therapy for children, adolescents and adult patients with a confirmed diagnosis of Type I Gaucher disease who exhibit signs and symptoms that are severe enough to result in one or more of the following conditions: a) moderate-to-severe anemia; b) thrombocytopenia with bleeding tendency; c) bone disease; d) significant hepatomegaly or splenomegaly.
- Company: Genzyme Corporation
- Alitretinoin
- Trade Name: Panretin
- Indication: Topical treatment of cutaneous lesions in patients with AIDS-related Kaposi's sarcoma.
- Company: Eisai, Inc
- Allopurinol sodium
- Trade Name: Aloprim For Injection
- Indication: Management of patients with leukemia, lymphoma, and solid tumor malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels and who cannot tolerate oral therapy.
- Company: Catalytica Pharmaceuticals, Inc
- Alpha1-proteinase inhibitor (human)
- Trade Name: Prolastin
- Indication: For chronic replacement therapy of individuals having congenital deficiency of alpha1- proteinase inhibitor with clinically demonstrable panacinar emphysema.
- Company: Bayer Corporation
- Altretamine
- Trade Name: Hexalen
- Indication: Single agent palliative treatment of patients with persistent or recurrent ovarian cancer following first-line therapy with a cisplatin and/or alkylating agent based combination.
- Company: Medimmune Oncology, Inc.
